Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10471782rdf:typepubmed:Citationlld:pubmed
pubmed-article:10471782lifeskim:mentionsumls-concept:C1521994lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C1704899lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C0128546lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C1332689lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C1332690lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C1707085lld:lifeskim
pubmed-article:10471782lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:10471782pubmed:issue2lld:pubmed
pubmed-article:10471782pubmed:dateCreated1999-10-14lld:pubmed
pubmed-article:10471782pubmed:abstractTextWe compared the anti-HIV-1 activity of CC-chemokine LD78beta with that of MIP-1alpha, another CC-chemokine which shows 94% sequence homology with LD78beta. Despite its close similarity to MIP-1alpha, the anti-HIV-1 activity of LD78beta appeared to be nearly 10 times higher than that of MIP-1alpha. Mutagenesis of MIP-1alpha showed that the N-terminal additional tetrapeptide, which was present in LD78beta and absent in MIP-1alpha, is responsible for enhanced anti-HIV-1 activity. The N-terminal structure-function relationship of LD78beta described here will be of value in understanding the chemokine-receptor interactions and designing anti-HIV-1 compounds based on LD78beta.lld:pubmed
pubmed-article:10471782pubmed:languageenglld:pubmed
pubmed-article:10471782pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:citationSubsetIMlld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10471782pubmed:statusMEDLINElld:pubmed
pubmed-article:10471782pubmed:monthAuglld:pubmed
pubmed-article:10471782pubmed:issn0014-5793lld:pubmed
pubmed-article:10471782pubmed:authorpubmed-author:NagaiYYlld:pubmed
pubmed-article:10471782pubmed:authorpubmed-author:KatzLLlld:pubmed
pubmed-article:10471782pubmed:authorpubmed-author:SakaiYYlld:pubmed
pubmed-article:10471782pubmed:authorpubmed-author:LiuHHlld:pubmed
pubmed-article:10471782pubmed:authorpubmed-author:ShiodaTTlld:pubmed
pubmed-article:10471782pubmed:authorpubmed-author:XieQQlld:pubmed
pubmed-article:10471782pubmed:issnTypePrintlld:pubmed
pubmed-article:10471782pubmed:day27lld:pubmed
pubmed-article:10471782pubmed:volume457lld:pubmed
pubmed-article:10471782pubmed:ownerNLMlld:pubmed
pubmed-article:10471782pubmed:authorsCompleteYlld:pubmed
pubmed-article:10471782pubmed:pagination219-22lld:pubmed
pubmed-article:10471782pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:meshHeadingpubmed-meshheading:10471782...lld:pubmed
pubmed-article:10471782pubmed:year1999lld:pubmed
pubmed-article:10471782pubmed:articleTitleEnhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.lld:pubmed
pubmed-article:10471782pubmed:affiliationDepartment of Viral Infection, Institute of Medical Science, University of Tokyo, Tokyo, Japan.lld:pubmed
pubmed-article:10471782pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10471782pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6349entrezgene:pubmedpubmed-article:10471782lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10471782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10471782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10471782lld:pubmed